Indrayani Biotech Ltd. | Income Statement
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
17.20
83.00
-
-
-
Gross Income
17.20
83.00
-
-
-
SG&A Expense
680.60
929.30
1,291.60
1,027.80
1,236.00
EBIT
697.80
1,010.60
1,291.60
1,030.30
1,238.00
Unusual Expense
-
-
-
7.50
-
Non Operating Income/Expense
-
0.10
-
0.10
-
Interest Expense
0.60
0.60
0.60
0.70
2.00
Pretax Income
698.40
1,011.20
1,292.10
1,038.40
1,240.00
Consolidated Net Income
698.40
1,011.20
1,292.10
1,038.40
1,240.00
Net Income
698.40
1,011.20
1,292.10
1,038.40
1,240.00
Net Income After Extraordinaries
698.40
1,011.20
1,292.10
1,038.40
1,240.00
Net Income Available to Common
698.40
1,011.20
1,292.10
1,038.40
1,240.00
EPS (Basic)
0.19
0.28
0.35
0.28
0.34
Basic Shares Outstanding
3,643.90
3,643.90
3,643.90
3,643.90
-
EPS (Diluted)
0.19
0.28
0.35
0.28
-
Diluted Shares Outstanding
3,643.90
3,643.90
3,643.90
3,643.90
-
EBITDA
680.70
927.60
-
-
-
Other Operating Expense
-
1.60
-
2.50
3.00
About Indrayani Biotech
View Profile
